Data:
{
"symbol": "IMNM",
"price": 27.1,
"marketCap": 2590630950,
"beta": 2.117,
"lastDividend": 0,
"range": "8.665-30.06",
"change": -0.23,
"changePercentage": -0.84157,
"volume": 143003.726,
"averageVolume": 1279215,
"companyName": "Immunome, Inc.",
"currency": "USD",
"cik": "0001472012",
"isin": "US45257U1088",
"cusip": "45257U108",
"exchangeFullName": "NASDAQ",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.immunome.com",
"description": "Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.",
"ceo": "Clay Siegall",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "247",
"phone": "610 321 3700",
"address": "18702 North Creek Parkway",
"city": "Bothell",
"state": "WA",
"zip": "98011",
"image": "https://images.financialmodelingprep.com/symbol/IMNM.png",
"ipoDate": "2020-10-02",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "IMNM",
"name": "Immunome, Inc.",
"price": 27.095,
"changePercentage": -0.85986,
"change": -0.235,
"volume": 143003.726,
"dayLow": 26.945,
"dayHigh": 27.6,
"yearHigh": 30.06,
"yearLow": 8.665,
"marketCap": 2590152974,
"priceAvg50": 24.5929,
"priceAvg200": 22.22763,
"exchange": "NASDAQ",
"open": 27.6,
"previousClose": 27.33,
"timestamp": 1788450284,
"chart_vwap_daily": [
{
"t": "2026-07-24",
"v": 22.1812,
"c": 22.21
},
{
"t": "2026-07-27",
"v": 22.7839,
"c": 22.58
},
{
"t": "2026-07-28",
"v": 23.0044,
"c": 23.22
},
{
"t": "2026-07-29",
"v": 23.2275,
"c": 23.11
},
{
"t": "2026-07-30",
"v": 22.9977,
"c": 23.08
},
{
"t": "2026-07-31",
"v": 22.889,
"c": 22.76
},
{
"t": "2026-08-03",
"v": 22.8748,
"c": 23.01
},
{
"t": "2026-08-04",
"v": 24.8613,
"c": 25.06
},
{
"t": "2026-08-05",
"v": 25.327,
"c": 25.52
},
{
"t": "2026-08-06",
"v": 25.7845,
"c": 25.82
},
{
"t": "2026-08-07",
"v": 25.1606,
"c": 25.03
},
{
"t": "2026-08-10",
"v": 25.6654,
"c": 25.69
},
{
"t": "2026-08-11",
"v": 26.1412,
"c": 26.25
},
{
"t": "2026-08-12",
"v": 27.2503,
"c": 27.99
},
{
"t": "2026-08-13",
"v": 26.8249,
"c": 26.42
},
{
"t": "2026-08-14",
"v": 26.7395,
"c": 27.2
},
{
"t": "2026-08-17",
"v": 27.3969,
"c": 27.4
},
{
"t": "2026-08-18",
"v": 27.3349,
"c": 27.56
},
{
"t": "2026-08-19",
"v": 29.327,
"c": 29.825
},
{
"t": "2026-08-20",
"v": 28.3231,
"c": 28.08
},
{
"t": "2026-08-21",
"v": 28.7366,
"c": 28.52
},
{
"t": "2026-08-24",
"v": 28.0573,
"c": 28.01
},
{
"t": "2026-08-25",
"v": 29.3716,
"c": 29.385
},
{
"t": "2026-08-26",
"v": 28.872,
"c": 28.75
},
{
"t": "2026-08-27",
"v": 28.8749,
"c": 28.87
},
{
"t": "2026-08-28",
"v": 27.6988,
"c": 27.57
},
{
"t": "2026-08-31",
"v": 27.3419,
"c": 27.41
},
{
"t": "2026-09-01",
"v": 26.9628,
"c": 27.065
},
{
"t": "2026-09-02",
"v": 27.2974,
"c": 27.33
},
{
"t": "2026-09-03",
"v": 27.1166,
"c": 27.08
}
],
"vwap_summary": {
"days": 30,
"days_above": 18,
"days_below": 12,
"pct_days_above": 60,
"position": "below",
"gap_pct": -0.13,
"streak_days": 1
}
}
Data:
{
"volume": 143003.726,
"avgVolume": 1279215,
"short_ratio": [
{
"symbol": "IMNM",
"file_date": "2026-09-02",
"date": "20260902",
"short_volume": 139032,
"short_exempt_volume": 0,
"total_volume": 297645,
"short_volume_ratio": 0.4671,
"signal": "Neutral"
}
],
"volume_profile": {
"poc": 27.43,
"vah": 29.51,
"val": 26.54,
"profile": [
{
"price": 24.88,
"volume": 73708
},
{
"price": 24.97,
"volume": 168706
},
{
"price": 25.05,
"volume": 214633
},
{
"price": 25.14,
"volume": 49614
},
{
"price": 25.22,
"volume": 7463
},
{
"price": 25.31,
"volume": 53551
},
{
"price": 25.39,
"volume": 1770
},
{
"price": 25.48,
"volume": 85801
},
{
"price": 25.56,
"volume": 85652
},
{
"price": 25.65,
"volume": 349845
},
{
"price": 25.73,
"volume": 207425
},
{
"price": 25.82,
"volume": 265958
},
{
"price": 25.9,
"volume": 178319
},
{
"price": 25.99,
"volume": 149805
},
{
"price": 26.07,
"volume": 204014
},
{
"price": 26.16,
"volume": 169749
},
{
"price": 26.24,
"volume": 368407
},
{
"price": 26.33,
"volume": 185933
},
{
"price": 26.41,
"volume": 217810
},
{
"price": 26.5,
"volume": 50982
},
{
"price": 26.58,
"volume": 149295
},
{
"price": 26.67,
"volume": 185532
},
{
"price": 26.75,
"volume": 101257
},
{
"price": 26.84,
"volume": 244392
},
{
"price": 26.92,
"volume": 321997
},
{
"price": 27.01,
"volume": 421936
},
{
"price": 27.09,
"volume": 646540
},
{
"price": 27.18,
"volume": 578669
},
{
"price": 27.26,
"volume": 339259
},
{
"price": 27.35,
"volume": 583426
},
{
"price": 27.43,
"volume": 746025
},
{
"price": 27.52,
"volume": 626860
},
{
"price": 27.6,
"volume": 442729
},
{
"price": 27.69,
"volume": 110482
},
{
"price": 27.77,
"volume": 60088
},
{
"price": 27.86,
"volume": 158169
},
{
"price": 27.94,
"volume": 187984
},
{
"price": 28.03,
"volume": 125004
},
{
"price": 28.11,
"volume": 244247
},
{
"price": 28.2,
"volume": 248138
},
{
"price": 28.28,
"volume": 228337
},
{
"price": 28.37,
"volume": 270648
},
{
"price": 28.45,
"volume": 166943
},
{
"price": 28.54,
"volume": 327799
},
{
"price": 28.62,
"volume": 326369
},
{
"price": 28.71,
"volume": 162688
},
{
"price": 28.79,
"volume": 354702
},
{
"price": 28.88,
"volume": 663374
},
{
"price": 28.96,
"volume": 508372
},
{
"price": 29.05,
"volume": 317216
},
{
"price": 29.13,
"volume": 258224
},
{
"price": 29.22,
"volume": 380775
},
{
"price": 29.3,
"volume": 126171
},
{
"price": 29.39,
"volume": 461135
},
{
"price": 29.47,
"volume": 257148
},
{
"price": 29.56,
"volume": 353479
},
{
"price": 29.64,
"volume": 393513
},
{
"price": 29.73,
"volume": 54828
},
{
"price": 29.81,
"volume": 627323
},
{
"price": 29.9,
"volume": 79325
}
],
"sessions": 20
}
}
Data:
{
"symbol": "IMNM",
"marketCap": 2590630950,
"enterpriseValueTTM": 2378010045,
"evToSalesTTM": 0,
"evToOperatingCashFlowTTM": -11.386938019952776,
"evToFreeCashFlowTTM": -10.851962014916516,
"evToEBITDATTM": -9.462813435330828,
"netDebtToEBITDATTM": 0.8482375979112271,
"currentRatioTTM": 15.07711477613194,
"incomeQualityTTM": 0.820975688396252,
"grahamNumberTTM": null,
"grahamNetNetTTM": 4.2348599596138286,
"taxBurdenTTM": 1,
"interestBurdenTTM": 1,
"workingCapitalTTM": 502736000,
"investedCapitalTTM": 524037000,
"returnOnAssetsTTM": -0.4498234828010697,
"operatingReturnOnAssetsTTM": -0.45641322470249146,
"returnOnTangibleAssetsTTM": -0.4498234828010697,
"returnOnEquityTTM": -0.5056045359142081,
"returnOnInvestedCapitalTTM": -0.510628295677883,
"returnOnCapitalEmployedTTM": -0.510628295677883,
"earningsYieldTTM": -0.08284956046670551,
"freeCashFlowYieldTTM": -0.0845685874323396,
"capexToOperatingCashFlowTTM": -0.04929762970980828,
"capexToDepreciationTTM": 3.007011393514461,
"capexToRevenueTTM": 0,
"salesGeneralAndAdministrativeToRevenueTTM": 0,
"researchAndDevelopementToRevenueTTM": 0,
"stockBasedCompensationToRevenueTTM": 0,
"intangiblesToTotalAssetsTTM": 0,
"averageReceivablesTTM": 0,
"averagePayablesTTM": 5765000,
"averageInventoryTTM": 0,
"daysOfSalesOutstandingTTM": 0,
"daysOfPayablesOutstandingTTM": 43.81812357345934,
"daysOfInventoryOutstandingTTM": 0,
"operatingCycleTTM": 0,
"cashConversionCycleTTM": -43.81812357345934,
"freeCashFlowToEquityTTM": -219086000,
"freeCashFlowToFirmTTM": -219086000,
"tangibleAssetValueTTM": 525083000,
"netCurrentAssetValueTTM": 498148000,
"grossProfitMarginTTM": 0,
"ebitMarginTTM": 0,
"ebitdaMarginTTM": 0,
"operatingProfitMarginTTM": 0,
"pretaxProfitMarginTTM": 0,
"continuousOperationsProfitMarginTTM": 0,
"netProfitMarginTTM": 0,
"bottomLineProfitMarginTTM": 0,
"receivablesTurnoverTTM": 0,
"payablesTurnoverTTM": 8.329886591060706,
"inventoryTurnoverTTM": 0,
"fixedAssetTurnoverTTM": 0,
"assetTurnoverTTM": 0,
"quickRatioTTM": 15.07711477613194,
"solvencyRatioTTM": -6.23428699039726,
"cashRatioTTM": 6.0959874555484,
"priceToEarningsRatioTTM": -10.671338582677164,
"priceToEarningsGrowthRatioTTM": -0.6356084679593539,
"forwardPriceToEarningsGrowthRatioTTM": -1.7178169341291647,
"priceToEarningsDilutedRatioTTM": -10.671338582677164,
"priceToEarningsDilutedGrowthRatioTTM": -0.6356084679593539,
"priceToBookRatioTTM": 5.847238340112325,
"priceToSalesRatioTTM": 0,
"priceToFreeCashFlowRatioTTM": -11.826990519704589,
"priceToOperatingCashFlowRatioTTM": -14.704925209854736,
"debtToAssetsRatioTTM": 0.008114838764450356,
"debtToEquityRatioTTM": 0.008737666235623701,
"debtToCapitalRatioTTM": 0.008661980738987031,
"longTermDebtToCapitalRatioTTM": 0.008661980738987031,
"financialLeverageRatioTTM": 1.076751675449405,
"workingCapitalTurnoverRatioTTM": 0,
"operatingCashFlowRatioTTM": -5.846414470920953,
"operatingCashFlowSalesRatioTTM": 0,
"freeCashFlowOperatingCashFlowRatioTTM": 1.0492976297098082,
"debtServiceCoverageRatioTTM": 0,
"interestCoverageRatioTTM": 0,
"shortTermOperatingCashFlowCoverageRatioTTM": 0,
"operatingCashFlowCoverageRatioTTM": -45.50850043591979,
"capitalExpenditureCoverageRatioTTM": -20.28495093753036,
"dividendPaidAndCapexCoverageRatioTTM": -20.28495093753036,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 0,
"netIncomePerShareTTM": -2.2452230886477196,
"interestDebtPerShareTTM": 0.04050393999251242,
"cashPerShareTTM": 4.590646639133934,
"bookValuePerShareTTM": 4.6355558681535305,
"tangibleBookValuePerShareTTM": 4.6355558681535305,
"shareholdersEquityPerShareTTM": 4.6355558681535305,
"operatingCashFlowPerShareTTM": -1.8432735708057206,
"capexPerShareTTM": 0.09086901794745648,
"freeCashFlowPerShareTTM": -1.9341425887531771,
"netIncomePerEBTTTM": 1,
"ebtPerEbitTTM": 0.9403176011683582,
"priceToFairValueTTM": 5.847238340112325,
"debtToMarketCapTTM": 0.001770657381773659,
"effectiveTaxRateTTM": 0,
"enterpriseValueMultipleTTM": -9.464791938642298,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 6941000
}
],
"dcf": {
"symbol": "IMNM",
"date": "2026-09-03",
"dcf": 7.3799376571167,
"Stock Price": 27.33
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "IMNM",
"reportedCurrency": "USD",
"cik": "0001472012",
"filingDate": "2026-03-03",
"acceptedDate": "2026-03-03 16:07:53",
"fiscalYear": "2025",
"period": "FY",
"revenue": 6941000,
"costOfRevenue": 2955000,
"grossProfit": 3986000,
"researchAndDevelopmentExpenses": 174331000,
"generalAndAdministrativeExpenses": 43768000,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 43768000,
"otherExpenses": 0,
"operatingExpenses": 218099000,
"costAndExpenses": 221054000,
"netInterestIncome": 11719000,
"interestIncome": 11719000,
"interestExpense": 0,
"depreciationAndAmortization": 2955000,
"ebitda": -209439000,
"ebit": -212394000,
"nonOperatingIncomeExcludingInterest": -1719000,
"operatingIncome": -214113000,
"totalOtherIncomeExpensesNet": 1719000,
"incomeBeforeTax": -212394000,
"incomeTaxExpense": 0,
"netIncomeFromContinuingOperations": -212394000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -212394000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -212394000,
"eps": -2.43,
"epsDiluted": -2.43,
"weightedAverageShsOut": 87350956,
"weightedAverageShsOutDil": 87350956
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "IMNM",
"reportedCurrency": "USD",
"cik": "0001472012",
"filingDate": "2026-03-03",
"acceptedDate": "2026-03-03 16:07:53",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 653482000,
"shortTermInvestments": 0,
"cashAndShortTermInvestments": 653482000,
"netReceivables": 0,
"accountsReceivables": 0,
"otherReceivables": 0,
"inventory": 0,
"prepaids": 0,
"otherCurrentAssets": 7295000,
"totalCurrentAssets": 660777000,
"propertyPlantEquipmentNet": 17614000,
"goodwill": 0,
"intangibleAssets": 0,
"goodwillAndIntangibleAssets": 0,
"longTermInvestments": 210000,
"taxAssets": 0,
"otherNonCurrentAssets": 4587000,
"totalNonCurrentAssets": 22411000,
"otherAssets": 0,
"totalAssets": 683188000,
"totalPayables": 3339000,
"accountPayables": 3339000,
"otherPayables": 0,
"accruedExpenses": 26498000,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 15153000,
"totalCurrentLiabilities": 44990000,
"longTermDebt": 3855000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 0,
"totalNonCurrentLiabilities": 3855000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 48845000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 11000,
"retainedEarnings": -728164000,
"additionalPaidInCapital": 1362496000,
"accumulatedOtherComprehensiveIncomeLoss": 0,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 634343000,
"totalEquity": 634343000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 683188000,
"totalInvestments": 210000,
"totalDebt": 3855000,
"netDebt": -649627000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "IMNM",
"reportedCurrency": "USD",
"cik": "0001472012",
"filingDate": "2026-03-03",
"acceptedDate": "2026-03-03 16:07:53",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -212394000,
"depreciationAndAmortization": 2955000,
"deferredIncomeTax": 0,
"stockBasedCompensation": 25690000,
"changeInWorkingCapital": -15227000,
"accountsReceivables": 0,
"inventory": 0,
"accountsPayables": -9164000,
"otherWorkingCapital": -6063000,
"otherNonCashItems": 8057000,
"netCashProvidedByOperatingActivities": -190919000,
"investmentsInPropertyPlantAndEquipment": -9685000,
"acquisitionsNet": 0,
"purchasesOfInvestments": -123266000,
"salesMaturitiesOfInvestments": 200000000,
"otherInvestingActivities": -6246000,
"netCashProvidedByInvestingActivities": 60803000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 640357000,
"netCommonStockIssuance": 640357000,
"commonStockIssuance": 640357000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": 640357000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": 510241000,
"cashAtEndOfPeriod": 653692000,
"cashAtBeginningOfPeriod": 143451000,
"operatingCashFlow": -190919000,
"capitalExpenditure": -9685000,
"freeCashFlow": -200604000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 27.1,
"rsi": 52.780745690085446,
"sma20": 27.573499999999978,
"sma50": 24.7402,
"sma200": 22.277500000000035,
"adx": 39.813522735324305,
"atr": 1.25,
"atr_pct": 4.61,
"atr_expansion_pct": -23.3,
"di_plus": 29.0,
"di_minus": 14.1,
"high_52w": 29.83,
"low_52w": 8.99,
"structure": {
"ema8": 27.58270200195048,
"ema21": 27.057948941533244,
"ema50": 25.274443444836738,
"ema200": 21.506534236636973,
"ema10": 27.601482929785462,
"ema20": 27.127366780356788,
"ema10_slope_pct": -2.11,
"ema20_slope_pct": 0.36,
"trend_dir": "chop",
"checks": {
"price_above_all": false,
"ema_stacked": true,
"ema21_rising": false,
"ema50_rising": true,
"adx_over_30": true,
"higher_highs_lows": false,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 0.2,
"_no_bars": false,
"macd": {
"macd": 0.861,
"signal": 1.188,
"histogram": -0.327
},
"bollinger": {
"mid": 27.57,
"upper": 29.89,
"lower": 25.26,
"width_pct": 16.79
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -3.5,
"ret_3d": -1.13,
"ret_5d": -6.13,
"roc10_accel": -12.76,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.13,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": -1.55,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": false,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 34666726.5,
"avg_vol": 1279215
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.0,
"iv_rank": 9.0
}
}
}
}
Data:
{
"prior_day": {
"high": 28.27,
"low": 26.92,
"close": 27.08,
"date": "2026-09-03"
},
"woodie_pivots": {
"PP": 27.34,
"R1": 27.75,
"S1": 26.4,
"R2": 28.69,
"S2": 25.99
},
"swing": {
"high_20d": 30.06,
"low_20d": 24.49,
"high_60d": 30.06,
"low_60d": 17.83
},
"orb": {
"high": 28.27,
"low": 26.94,
"date": "2026-09-03"
},
"vwap": 27.12,
"volume_profile": {
"poc": 27.43,
"vah": 29.51,
"val": 26.54,
"sessions": 20
},
"premarket": {
"date": "2026-09-03",
"high": 26.69,
"low": 26.69,
"last": 26.69,
"volume": 100,
"gap_pct": -2.34,
"path": "09:15 26.69",
"bars": 1,
"last_bar_et": "09:15"
},
"recent_daily": [
{
"d": "2026-07-31",
"o": 23.7,
"h": 23.7,
"l": 22.48,
"c": 22.76,
"v": 658124.740821
},
{
"d": "2026-08-03",
"o": 22.67,
"h": 23.068,
"l": 22.12,
"c": 23.01,
"v": 1771166.144456
},
{
"d": "2026-08-04",
"o": 23.36,
"h": 25.37,
"l": 23.0901,
"c": 25.06,
"v": 1802153.425829
},
{
"d": "2026-08-05",
"o": 25.3,
"h": 25.84,
"l": 24.89,
"c": 25.52,
"v": 1092754.600294
},
{
"d": "2026-08-06",
"o": 25.44,
"h": 26.42,
"l": 25.315,
"c": 25.82,
"v": 860149.988712
},
{
"d": "2026-08-07",
"o": 26.19,
"h": 26.25,
"l": 24.8,
"c": 25.03,
"v": 881139.895765
},
{
"d": "2026-08-10",
"o": 24.985,
"h": 26.1497,
"l": 24.49,
"c": 25.69,
"v": 1232630.095861
},
{
"d": "2026-08-11",
"o": 25.81,
"h": 26.47,
"l": 25.42,
"c": 26.25,
"v": 886891.582603
},
{
"d": "2026-08-12",
"o": 25.23,
"h": 28.04,
"l": 25.23,
"c": 27.99,
"v": 1561640.884144
},
{
"d": "2026-08-13",
"o": 28.6,
"h": 28.62,
"l": 26.33,
"c": 26.42,
"v": 946921.568615
},
{
"d": "2026-08-14",
"o": 26.38,
"h": 27.3,
"l": 25.59,
"c": 27.2,
"v": 760764.219512
},
{
"d": "2026-08-17",
"o": 26.89,
"h": 27.8,
"l": 26.6901,
"c": 27.4,
"v": 1187272.826745
},
{
"d": "2026-08-18",
"o": 27.1,
"h": 27.69,
"l": 26.7598,
"c": 27.56,
"v": 965338.268642
},
{
"d": "2026-08-19",
"o": 27.85,
"h": 30.06,
"l": 27.625,
"c": 29.825,
"v": 2984904.232479
},
{
"d": "2026-08-20",
"o": 29.13,
"h": 29.15,
"l": 27.89,
"c": 28.08,
"v": 1025508.954083
},
{
"d": "2026-08-21",
"o": 28.46,
"h": 29.3,
"l": 28.125,
"c": 28.52,
"v": 848794.767431
},
{
"d": "2026-08-24",
"o": 28.48,
"h": 28.848,
"l": 27.64,
"c": 28.01,
"v": 1355475.028285
},
{
"d": "2026-08-25",
"o": 27.88,
"h": 29.72,
"l": 27.88,
"c": 29.385,
"v": 1928775.370407
},
{
"d": "2026-08-26",
"o": 29.34,
"h": 29.385,
"l": 28.62,
"c": 28.75,
"v": 559029.638929
},
{
"d": "2026-08-27",
"o": 28.57,
"h": 29.11,
"l": 28.35,
"c": 28.87,
"v": 1055468.598513
},
{
"d": "2026-08-28",
"o": 28.45,
"h": 28.77,
"l": 27.4,
"c": 27.57,
"v": 784509.613269
},
{
"d": "2026-08-31",
"o": 27.48,
"h": 27.63,
"l": 27,
"c": 27.41,
"v": 1050739.09171
},
{
"d": "2026-09-01",
"o": 27.23,
"h": 27.305,
"l": 26.64,
"c": 27.065,
"v": 700168.474388
},
{
"d": "2026-09-02",
"o": 27.56,
"h": 28.485,
"l": 26.81,
"c": 27.33,
"v": 811103.941968
},
{
"d": "2026-09-03",
"o": 27.6,
"h": 28.27,
"l": 26.92,
"c": 27.08,
"v": 142854.726002
}
]
}
Data:
{
"estimates": [
{
"symbol": "IMNM",
"date": "2030-12-31",
"revenueLow": 212434372,
"revenueHigh": 1055270132,
"revenueAvg": 594116000,
"ebitdaLow": 102214590,
"ebitdaHigh": 271466468,
"ebitdaAvg": 178861185,
"ebitLow": 15127194,
"ebitHigh": 184379072,
"ebitAvg": 91773789,
"netIncomeLow": 11950484,
"netIncomeHigh": 145659467,
"netIncomeAvg": 72501294,
"sgaExpenseLow": 567329338,
"sgaExpenseHigh": 2818214869,
"sgaExpenseAvg": 1586652075,
"epsAvg": 0.83,
"epsHigh": 1.66752,
"epsLow": 0.13681,
"numAnalystsRevenue": 5,
"numAnalystsEps": 5
},
{
"symbol": "IMNM",
"date": "2029-12-31",
"revenueLow": 133178688,
"revenueHigh": 661566630,
"revenueAvg": 372461333,
"ebitdaLow": -33541869,
"ebitdaHigh": 41022255,
"ebitdaAvg": 7255395,
"ebitLow": -81228528,
"ebitHigh": -6664403,
"ebitAvg": -40431263,
"netIncomeLow": -81228528,
"netIncomeHigh": -6664403,
"netIncomeAvg": -40431263,
"sgaExpenseLow": 355668323,
"sgaExpenseHigh": 1766786396,
"sgaExpenseAvg": 994698925,
"epsAvg": -0.46286,
"epsHigh": -0.07629457,
"epsLow": -0.92991,
"numAnalystsRevenue": 5,
"numAnalystsEps": 5
},
{
"symbol": "IMNM",
"date": "2028-12-31",
"revenueLow": 74183702,
"revenueHigh": 330216697,
"revenueAvg": 196800526,
"ebitdaLow": -197102597,
"ebitdaHigh": -34891870,
"ebitdaAvg": -165789232,
"ebitLow": -218360795,
"ebitHigh": -56150068,
"ebitAvg": -187047430,
"netIncomeLow": -218360795,
"netIncomeHigh": -56150068,
"netIncomeAvg": -187047430,
"sgaExpenseLow": 198115729,
"sgaExpenseHigh": 881879982,
"sgaExpenseAvg": 525577434,
"epsAvg": -1.50102,
"epsHigh": -0.64281,
"epsLow": -2.49981,
"numAnalystsRevenue": 10,
"numAnalystsEps": 8
},
{
"symbol": "IMNM",
"date": "2027-12-31",
"revenueLow": 28995265,
"revenueHigh": 98431837,
"revenueAvg": 53346357,
"ebitdaLow": -239013174,
"ebitdaHigh": -159518562,
"ebitdaAvg": -199265868,
"ebitLow": -245322542,
"ebitHigh": -165827930,
"ebitAvg": -205575236,
"netIncomeLow": -245322542,
"netIncomeHigh": -165827930,
"netIncomeAvg": -205575236,
"sgaExpenseLow": 77435041,
"sgaExpenseHigh": 262873039,
"sgaExpenseAvg": 142467309,
"epsAvg": -2.46597,
"epsHigh": -1.89841,
"epsLow": -2.80847,
"numAnalystsRevenue": 8,
"numAnalystsEps": 9
}
],
"price_target": {
"symbol": "IMNM",
"targetHigh": 37,
"targetLow": 33,
"targetConsensus": 35.25,
"targetMedian": 35.5
},
"ratings": {
"symbol": "IMNM",
"rating": "C+",
"overallScore": 2,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 1,
"returnOnAssetsScore": 1,
"debtToEquityScore": 4,
"priceToEarningsScore": 1,
"priceToBookScore": 2
},
"grades": [
{
"symbol": "IMNM",
"date": "2026-08-12",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-08-12",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-07-21",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-06-12",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-05-28",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-05-15",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-05-13",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-03-04",
"gradingCompany": "Stephens & Co.",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-03-04",
"gradingCompany": "Craig-Hallum",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2026-01-15",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2025-12-16",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2025-12-16",
"gradingCompany": "Lake Street",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2025-12-16",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "IMNM",
"date": "2025-11-17",
"gradingCompany": "Stephens & Co.",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Immunome to Present at the H.C. Wainwright 28th Annual Global Investment Conference",
"url": "https://www.businesswire.com/news/home/20260902093802/en/Immunome-to-Present-at-the-H.C.-Wainwright-28th-Annual-Global-Investment-Conference/",
"source": "Business Wire",
"date": "2026-09-02 07:45:00",
"summary": "BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at H.C. Wainwright's 28th Annual Glob",
"image": "https://images.financialmodelingprep.com/news/immunome-to-present-at-the-hc-wainwright-28th-annual-20260902.jpg"
},
{
"title": "Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story",
"url": "https://finance.yahoo.com/healthcare/articles/argenx-just-landed-another-phase-090600333.html",
"source": "Yahoo! Finance",
"date": "2026-08-26T09:06:00Z",
"summary": "Argenx (NASDAQ: ARGX) already markets Vyvgart Hytrulo for treating generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), two rare chronic autoimmune diseases. It appears to be on track to add another approved indication for the drug.\n\nO",
"image": "https://s.yimg.com/lo/mysterio/api/6377f6097307b460c17a7e9e735520a8efd7335b746ba0651cf4b671c883adf8/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fmotleyfool.com%2F12b4f1d55740d504fdeb458878b75934.jpg"
},
{
"title": "argenx SE (ARGX) Won Its Phase 3 Myositis Trial. How Much Does the Subgroup Miss Matter?",
"url": "https://finance.yahoo.com/healthcare/articles/argenx-se-argx-won-phase-005324473.html",
"source": "Yahoo! Finance",
"date": "2026-08-22T00:53:24Z",
"summary": "argenx SE (NASDAQ:ARGX) delivered a clearly positive headline result from the Phase 3 ALKIVIA trial. VYVGART Hytrulo produced a 15.4-point mean advantage over placebo on the Total Improvement Score, or TIS, at Week 52 in the combined immune-mediated necrotizing myopathy and derma",
"image": "https://s.yimg.com/lo/mysterio/api/303B7175C9F7DF22A5C9019911A60F01A79B5FFC98E68960E3D38EEFBFE97963/subgraphmysterio/resizefill_w1200_h673;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F5e12869f7fd21716d91f9d66b55c0bcb.jpg"
},
{
"title": "Europe Has Its Own Biotech Star as Argenx Soars on Trial Success",
"url": "https://www.bloomberg.com/news/articles/2026-08-21/europe-has-its-own-biotech-star-as-argenx-soars-on-trial-success",
"source": "Bloomberg Business",
"date": "2026-08-21T06:27:47Z",
"summary": "The latest late-stage study results for Vyvgart pave the way for regulatory submission and could open up another source of growth, with approval seeming very likely.\n\nIt's been a big week for biotech stocks on both sides of the Atlantic.\n\nModerna Inc.'s dizzying price action may ",
"image": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/isqaxIxuvNPo/v0/1200x800.jpg"
},
{
"title": "Could argenx SE (ARGX)'s Global Scale Give it an Edge Over Zai Lab Limited American Depositary Shares (ZLAB)?",
"url": "https://finance.yahoo.com/healthcare/articles/could-argenx-se-argx-global-222729843.html",
"source": "Yahoo! Finance",
"date": "2026-08-20T22:27:29Z",
"summary": "Zai Lab Limited American Depositary Shares (NASDAQ:ZLAB) and argenx SE (NASDAQ:ARGX) announced positive topline results on August 17 from their Phase 3 ALKIVIA study evaluating VYVGART Hytrulo in adults with autoimmune myositis. In the combined immune-mediated necrotizing myopath",
"image": "https://s.yimg.com/lo/mysterio/api/2B8650F474D8CE41DA747AECD2D3C8E1DF2ECEF1611781F0C3B962ADF5AF2A58/subgraphmysterio/resizefill_w1200_h673;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F4b9ae3e820991409356264f5ee1180f1.jpg"
},
{
"title": "Citizens raises argenx stock price target to $1,200 on trial results By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/citizens-raises-argenx-stock-price-target-to-1200-on-trial-results-93CH-4864521",
"source": "Investing.com",
"date": "2026-08-18T08:57:07Z",
"summary": "Investing.com - Citizens raised its price target on argenx SE (NASDAQ:ARGX) to $1,200 from $932 while maintaining a Market Outperform rating. The stock has surged 14% over the past week and currently trades at $987.84, near its 52-week high of $1,002.16.\n\nThe firm increased its r",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4519D_1200_L.jpg"
},
{
"title": "Argenx's stock rises on Phase III autoimmune myositis victory",
"url": "https://finance.yahoo.com/markets/stocks/articles/argenx-stock-rises-phase-iii-155114673.html",
"source": "Yahoo! Finance",
"date": "2026-08-17T15:51:14Z",
"summary": "Argenx's stock opened 8.9% up after a Phase III trial of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with autoimmune myositis met its primary endpoint.\n\nIn the Phase III ALKIVIA trial (NCT05523167), patients from the combined immune-mediated necrotising m",
"image": "https://s.yimg.com/lo/mysterio/api/B246CAC30A58207067DC1F9D3DC042118D2E159D02DE6D6D5CD17EA27667A8D6/subgraphmysterio/resizefill_w1200_h800;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fclinical_trials_arena_396%2F72aa9f3bb2180c4b290eb6eccfdc1bff.jpg"
},
{
"title": "Argenx shares jump after positive Phase 3 results in autoimmune myositis trial By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/argenx-shares-jump-after-positive-phase-3-results-in-autoimmune-myositis-trial-4862247",
"source": "Investing.com",
"date": "2026-08-17T07:21:38Z",
"summary": "Investing.com -- Shares of Argenx (EBR:ARGX) rose more than 7% in early Monday trading after the immunology company said its drug efgartigimod met the primary endpoint in a late-stage trial treating adults with autoimmune myositis, showing significant improvement in disease activ",
"image": "https://content-media.investing.com/news/LYNXNPEC1G0R8_L.jpg"
},
{
"title": "argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filing",
"url": "https://www.marketbeat.com/instant-alerts/argenx-vyvgart-hits-phase-iii-goal-in-autoimmune-myositis-eyes-imnm-filing-2026-08-17/",
"source": "MarketBeat",
"date": "2026-08-17 10:04:42",
"summary": "argenx NASDAQ: ARGX reported positive top-line results from its Phase III ALKIVIA trial of VYVGART Hytrulo in autoimmune myositis, meeting its primary endpoint in a combined population of patients with immune-mediated necrotizing myopathy, or IMNM, and dermatomyositis, or DM.",
"image": "https://images.financialmodelingprep.com/news/argenx-vyvgart-hits-phase-iii-goal-in-autoimmune-myositis-20260817.jpg"
},
{
"title": "argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis",
"url": "https://www.globenewswire.com/news-release/2026/08/17/3345813/0/en/argenx-announces-positive-topline-results-from-phase-3-alkivia-trial-of-efgartigimod-in-autoimmune-myositis.html",
"source": "GlobeNewsWire",
"date": "2026-08-17 01:00:00",
"summary": "Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; consistent treatment effect across IMNM and DM First Phase 3 study t",
"image": "https://images.financialmodelingprep.com/news/argenx-announces-positive-topline-results-from-phase-3-alkivia-20260817.jpg"
},
{
"title": "Immunome director Isaac Barchas sells $940,453 in common stock By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/immunome-director-isaac-barchas-sells-940453-in-common-stock-93CH-4861943",
"source": "Investing.com",
"date": "2026-08-16T08:01:24Z",
"summary": "Immunome Inc. (NASDAQ:IMNM) Director Isaac Barchas sold a total of $940,453 worth of the company's common stock across two transactions in early August 2026, according to a recent SEC filing. The sales were executed on August 6 and August 7, 2026, at weighted average prices of $2",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3S10Z_1200_L.jpg"
},
{
"title": "Immunome: Maintaining My 'Strong Buy' Rating With 2 Catalysts On The Horizon",
"url": "https://seekingalpha.com/article/4936313-immunome-maintaining-my-strong-buy-rating-with-two-catalysts-on-horizon",
"source": "Seeking Alpha",
"date": "2026-08-13 15:24:03",
"summary": "I am maintaining my \"Strong Buy\" rating on Immunome (IMNM). This decision is driven by FDA acceptance of varegacestat's NDA and a PDUFA date set for April 2027. The company's pipeline is diversified, with IM-1021 [ROR1 ADC] in phase 1 for B-cell lymphoma/solid tumors and initial ",
"image": "https://images.financialmodelingprep.com/news/immunome-maintaining-my-strong-buy-rating-with-2-catalysts-20260813.jpg"
},
{
"title": "Immunome director Isaac Barchas sells over $2.1m in shares By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/immunome-director-isaac-barchas-sells-over-21m-in-shares-93CH-4856388",
"source": "Investing.com",
"date": "2026-08-12T22:16:02Z",
"summary": "Isaac Barchas, a director at Immunome Inc. (NASDAQ:IMNM), recently sold shares of the company's common stock totaling approximately $2.19 million across three separate transactions in August 2026. These sales were conducted under pre-arranged Rule 10b5-1 trading plans.\n\nOn August",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3Q0WG_1200_L.jpg"
},
{
"title": "Immunome stock hits 52-week high at 27.68 USD By Investing.com",
"url": "https://www.investing.com/news/company-news/immunome-stock-hits-52week-high-at-2768-usd-93CH-4855616",
"source": "Investing.com",
"date": "2026-08-12T15:36:29Z",
"summary": "Immunome Inc (IMNM) has reached a significant milestone, with its stock price hitting a 52-week high of $27.68. The stock currently trades at $27.70 with a market capitalization of $3.12 billion, though InvestingPro analysis suggests the shares may be overvalued at current levels",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png"
},
{
"title": "Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update",
"url": "https://www.businesswire.com/news/home/20260811301534/en/Immunome-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Business-Update/",
"source": "Business Wire",
"date": "2026-08-11 16:02:00",
"summary": "BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the quarter ended June 30, 2026, and provided a business update. \u201cWe con",
"image": "https://images.financialmodelingprep.com/news/immunome-reports-second-quarter-2026-financial-results-and-provides-20260811.jpg"
},
{
"title": "Immunome CBO Kinney Horn sells $2.27m in company stock By Investing.com",
"url": "https://www.investing.com/news/insider-trading-news/immunome-cbo-kinney-horn-sells-227m-in-company-stock-93CH-4844921",
"source": "Investing.com",
"date": "2026-08-07T00:01:08Z",
"summary": "Kinney Horn, Chief Business Officer at Immunome Inc. (NASDAQ:IMNM), sold 90,616 shares of company common stock on August 4, 2026, for a total value of $2,273,555. The sale followed the exercise of employee stock options on the same day. The timing coincides with the stock trading",
"image": "https://i-invdn-com.investing.com/news/moved_LYNXMPEM4416N_1200_L.jpg"
},
{
"title": "Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
"url": "https://www.businesswire.com/news/home/20260806727611/en/Immunome-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4/",
"source": "Business Wire",
"date": "2026-08-06 16:02:00",
"summary": "BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the \u201cCompany\u201d) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on August 3, 2026, the Compensation Committee of the Company's Board of D",
"image": "https://images.financialmodelingprep.com/news/immunome-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20260806.jpg"
},
{
"title": "Atika Capital Management LLC Sells 71,441 Shares of Immunome, Inc. $IMNM",
"url": "https://www.defenseworld.net/2026/07/24/atika-capital-management-llc-sells-71441-shares-of-immunome-inc-imnm.html",
"source": "Defense World",
"date": "2026-07-24 03:58:28",
"summary": "Atika Capital Management LLC lessened its holdings in Immunome, Inc. (NASDAQ: IMNM) by 21.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 262,900 shares of the company's stock after ",
"image": "https://images.financialmodelingprep.com/news/atika-capital-management-llc-sells-71441-shares-of-immunome-20260724.png"
},
{
"title": "Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-3050, an FAP-Targeted Radioligand Therapy, in Patients with FAP-Expressing Advanced Solid Tumors",
"url": "https://www.businesswire.com/news/home/20260720175949/en/Immunome-Announces-First-Patient-Dosed-in-Phase-1-Trial-Evaluating-IM-3050-an-FAP-Targeted-Radioligand-Therapy-in-Patients-with-FAP-Expressing-Advanced-Solid-Tumors/",
"source": "Business Wire",
"date": "2026-07-20 07:30:00",
"summary": "BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the first patient has been dosed in the Phase 1, first-in-human trial of IM-3050, an in",
"image": "https://images.financialmodelingprep.com/news/immunome-announces-first-patient-dosed-in-phase-1-trial-20260720.jpg"
},
{
"title": "What This Immunome Sale Means a Day Before a Big FDA Milestone",
"url": "https://www.fool.com/coverage/filings/2026/07/12/what-this-immunome-sale-means-a-day-before-a-big-fda-milestone/",
"source": "The Motley Fool",
"date": "2026-07-12 16:44:53",
"summary": "An Immunome insider sold 100,000 shares for $2.4 million based on weighted average prices on July 6, 2026 and July 7, 2026. The transaction represents 32% of the insider's total equity holdings in the company.",
"image": "https://images.financialmodelingprep.com/news/what-this-immunome-sale-means-a-day-before-a-20260712.jpg"
},
{
"title": "Immunome Stock Up 32% in a Month: Here's What You Should Know",
"url": "https://www.zacks.com/stock/news/2951708/immunome-stock-up-32-in-a-month-here-s-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-analyst_blog|price_surge_/_plunge-2951708",
"source": "Zacks Investment Research",
"date": "2026-07-10 11:41:06",
"summary": "IMNM jumps 32% in a month. This comes as the FDA accepts varegacestat's NDA for desmoid tumors, with an approval decision expected by April 2027.",
"image": "https://images.financialmodelingprep.com/news/immunome-stock-up-32-in-a-month-heres-what-20260710.jpg"
},
{
"title": "Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors",
"url": "https://www.businesswire.com/news/home/20260708283482/en/Immunome-Announces-U.S.-FDA-Acceptance-of-New-Drug-Application-for-Varegacestat-for-the-Treatment-of-Adults-with-Desmoid-Tumors/",
"source": "Business Wire",
"date": "2026-07-08 07:30:00",
"summary": "BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the U.S. Food and Drug Administration (FDA or the Agency) has accepted its New Drug Applicat",
"image": "https://images.financialmodelingprep.com/news/immunome-announces-us-fda-acceptance-of-new-drug-application-for-20260708.jpg"
},
{
"title": "Immunome Announces First Patient Dosed in Phase 1 Trial Evaluating IM-1617, a Potential First-in-Class ADC, in Patients with Advanced Solid Tumors",
"url": "https://www.gurufocus.com/news/8911682/immunome-announces-first-patient-dosed-in-phase-1-trial-evaluating-im1617-a-potential-firstinclass-adc-in-patients-with-advanced-solid-tumors",
"source": "GuruFocus",
"date": "2026-06-11 08:00:00",
"summary": "[url=\"]Immunome, Inc.[/url] (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today a",
"image": "https://images.financialmodelingprep.com/news/immunome-announces-first-patient-dosed-in-phase-1-trial-evaluating-20260611.png"
},
{
"title": "Immunome, Inc. (IMNM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript",
"url": "https://seekingalpha.com/article/4913364-immunome-inc-imnm-presents-at-goldman-sachs-47th-annual-global-healthcare-conference-2026",
"source": "Seeking Alpha",
"date": "2026-06-09 14:52:10",
"summary": "Immunome, Inc. (IMNM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript",
"image": "https://images.financialmodelingprep.com/news/immunome-inc-imnm-presents-at-goldman-sachs-47th-annual-20260609.jpg"
},
{
"title": "Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More",
"url": "https://www.fool.com/coverage/filings/2026/04/04/immunome-s-chief-scientist-trimmed-his-stake-a-planned-fda-submission-tells-you-more/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-04-04T23:05:46Z",
"summary": "Jack Higgins, Chief Scientific Officer of Immunome, sold 9,438 shares (30% of his direct holdings) for approximately $204,000 on April 2, 2026, through a pre-arranged Rule 10b5-1 trading plan established in December 2025. The sale represents routine financial diversification rath",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2Fd227e0f40b399dc519a5bed98ee8a4568fc6efb8-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
}
]
Data:
[
{
"symbol": "IMNM",
"date": "2026-11-05",
"epsActual": null,
"epsEstimated": -0.64,
"revenueActual": null,
"revenueEstimated": 181818,
"lastUpdated": "2026-09-03"
},
{
"symbol": "IMNM",
"date": "2026-08-11",
"epsActual": -0.65,
"epsEstimated": -0.51381,
"revenueActual": null,
"revenueEstimated": 166667,
"lastUpdated": "2026-09-03"
},
{
"symbol": "IMNM",
"date": "2026-05-12",
"epsActual": -0.48,
"epsEstimated": -0.6,
"revenueActual": null,
"revenueEstimated": 222222,
"lastUpdated": "2026-08-12"
},
{
"symbol": "IMNM",
"date": "2026-03-03",
"epsActual": -0.75,
"epsEstimated": -0.59017,
"revenueActual": null,
"revenueEstimated": 876034,
"lastUpdated": "2026-06-02"
},
{
"symbol": "IMNM",
"date": "2025-11-06",
"epsActual": -0.65,
"epsEstimated": -0.57,
"revenueActual": null,
"revenueEstimated": 850000,
"lastUpdated": "2026-02-03"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "IMNM",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "IMNM",
"periods": [
{
"file_period": "202604b",
"settlement_date": "20260424",
"quantity_fails": 5241,
"price": 22.99
},
{
"file_period": "202606a",
"settlement_date": "20260611",
"quantity_fails": 999,
"price": 18.16
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 7085,
"price": 21.04
},
{
"file_period": "202607a",
"settlement_date": "20260709",
"quantity_fails": 4107,
"price": 24.01
},
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 347,
"price": 23.08
},
{
"file_period": "202608a",
"settlement_date": "20260811",
"quantity_fails": 7,
"price": 25.69
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "IMNM",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-12",
"reportingCik": "0001808343",
"companyCik": "0001472012",
"transactionType": "S-Sale",
"securitiesOwned": 92211,
"reportingName": "Barchas Isaac",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 11048,
"price": 27.25,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1472012/000180834326000010/0001808343-26-000010-index.htm"
},
{
"symbol": "IMNM",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-10",
"reportingCik": "0001808343",
"companyCik": "0001472012",
"transactionType": "S-Sale",
"securitiesOwned": 62291,
"reportingName": "Barchas Isaac",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 10125,
"price": 26.07,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1472012/000180834326000010/0001808343-26-000010-index.htm"
},
{
"symbol": "IMNM",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-11",
"reportingCik": "0001808343",
"companyCik": "0001472012",
"transactionType": "S-Sale",
"securitiesOwned": 0,
"reportingName": "Barchas Isaac",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 62291,
"price": 26.23,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1472012/000180834326000010/0001808343-26-000010-index.htm"
},
{
"symbol": "IMNM",
"filingDate": "2026-08-10",
"transactionDate": "2026-08-06",
"reportingCik": "0001808343",
"companyCik": "0001472012",
"transactionType": "S-Sale",
"securitiesOwned": 87664,
"reportingName": "Barchas Isaac",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 20840,
"price": 26.06,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1472012/000180834326000009/0001808343-26-000009-index.htm"
},
{
"symbol": "IMNM",
"filingDate": "2026-08-10",
"transactionDate": "2026-08-07",
"reportingCik": "0001808343",
"companyCik": "0001472012",
"transactionType": "S-Sale",
"securitiesOwned": 72416,
"reportingName": "Barchas Isaac",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 15248,
"price": 26.06,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1472012/000180834326000009/0001808343-26-000009-index.htm"
},
{
"symbol": "IMNM",
"filingDate": "2026-08-06",
"transactionDate": "2026-08-04",
"reportingCik": "0001831215",
"companyCik": "0001472012",
"transactionType": "M-Exempt",
"securitiesOwned": 120750,
"reportingName": "Horn Kinney",
"typeOfOwner": "officer: CHIEF BUSINESS OFFICER",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 40250,
"price": 10.6,
"securityName": "Employee Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1472012/000183121526000005/0001831215-26-000005-index.htm"
},
{
"symbol": "IMNM",
"filingDate": "2026-08-06",
"transactionDate": "2026-08-04",
"reportingCik": "0001831215",
"companyCik": "0001472012",
"transactionType": "M-Exempt",
"securitiesOwned": 90616,
"reportingName": "Horn Kinney",
"typeOfOwner": "officer: CHIEF BUSINESS OFFICER",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 40250,
"price": 10.6,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1472012/000183121526000005/0001831215-26-000005-index.htm"
},
{
"symbol": "IMNM",
"filingDate": "2026-08-06",
"transactionDate": "2026-08-04",
"reportingCik": "0001831215",
"companyCik": "0001472012",
"transactionType": "M-Exempt",
"securitiesOwned": 78542,
"reportingName": "Horn Kinney",
"typeOfOwner": "officer: CHIEF BUSINESS OFFICER",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 50366,
"price": 12.92,
"securityName": "Employee Stock Option (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/1472012/000183121526000005/0001831215-26-000005-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
"status",
"endpoint",
"provided",
"message"
],
"dark_pool": [
{
"ticker": "IMNM",
"executed_at": "2026-09-03T15:16:56.975000Z",
"size": 300.0,
"price": 27.07,
"premium": 8121.0,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "IMNM",
"executed_at": "2026-09-03T15:15:00.281000Z",
"size": 243.0,
"price": 27.07,
"premium": 6578.01,
"volume": 243.0,
"trade_code": " "
},
{
"ticker": "IMNM",
"executed_at": "2026-09-03T15:34:11.769000Z",
"size": 222.0,
"price": 27.0738,
"premium": 6010.3836,
"volume": 222.0,
"trade_code": " "
},
{
"ticker": "IMNM",
"executed_at": "2026-09-03T15:31:50.086000Z",
"size": 206.0,
"price": 27.1,
"premium": 5582.6,
"volume": 206.0,
"trade_code": " "
},
{
"ticker": "IMNM",
"executed_at": "2026-09-03T15:17:03.206000Z",
"size": 200.0,
"price": 27.1,
"premium": 5420.0,
"volume": 200.0,
"trade_code": "F"
},
{
"ticker": "IMNM",
"executed_at": "2026-09-03T15:39:30.903000Z",
"size": 193.0,
"price": 27.1,
"premium": 5230.3,
"volume": 193.0,
"trade_code": "F"
},
{
"ticker": "IMNM",
"executed_at": "2026-09-03T15:21:26.526000Z",
"size": 176.0,
"price": 27.07,
"premium": 4764.32,
"volume": 176.0,
"trade_code": " "
},
{
"ticker": "IMNM",
"executed_at": "2026-09-03T15:19:51.891000Z",
"size": 171.0,
"price": 27.05,
"premium": 4625.55,
"volume": 171.0,
"trade_code": " "
}
],
"ats": {
"symbol": "IMNM",
"date": "20260902",
"ats_volume": 0,
"total_volume": 297645,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260902",
"ats_ratio": 0.0
},
{
"date": "20260901",
"ats_ratio": 0.0
},
{
"date": "20260831",
"ats_ratio": 0.0
},
{
"date": "20260828",
"ats_ratio": 0.0
},
{
"date": "20260827",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "IMNM",
"days": [
{
"date": "2026-09-03",
"close": 27.08,
"vwap": 27.12,
"volume": 142854,
"vwap_discount_pct": 0.14
},
{
"date": "2026-09-02",
"close": 27.33,
"vwap": 27.3,
"volume": 811103,
"vwap_discount_pct": -0.12
},
{
"date": "2026-09-01",
"close": 27.065,
"vwap": 26.96,
"volume": 700168,
"vwap_discount_pct": -0.38
},
{
"date": "2026-08-31",
"close": 27.41,
"vwap": 27.34,
"volume": 1050739,
"vwap_discount_pct": -0.25
},
{
"date": "2026-08-28",
"close": 27.57,
"vwap": 27.7,
"volume": 784509,
"vwap_discount_pct": 0.47
}
],
"avg_vwap_discount_pct": -0.03,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "IMNM",
"net_call_premium": "-70.00",
"net_put_premium": "0",
"call_premium": "2591.00",
"put_premium": "0",
"bullish_premium": "1258.00",
"bearish_premium": "1328.00",
"put_call_ratio": "0.00000000000000000000",
"iv_rank": "9.3773",
"implied_move_perc": "0.113000",
"gex_ratio": "0.19811751597781402390",
"gex_net_change": "-2354.0775",
"gex_call": "20344.4914",
"gex_put": "-4030.6001",
"gex_net": 16313.8913,
"gex_call_delta": "196178.8647",
"gex_put_delta": "-17972.6284",
"gex_date": "2026-09-03"
},
"hot_chains": [
{
"underlying_symbol": "IMNM",
"expires": "2026-12-18",
"open_interest": 529,
"option_type": "call",
"delta": 0.440227655023431,
"ask_volume": 0,
"last_price": "2.50",
"implied_volatility": "0.609033973323839",
"gamma": 0.0446141847901427,
"avg_price": "2.50",
"bid_volume": 1,
"nbbo_ask": "3.10",
"strike": "30",
"option_symbol": "IMNM261218C00030000",
"total_premium": "250.00",
"iv": 0.605231518824429,
"volume": 1,
"nbbo_bid": "2.50"
},
{
"underlying_symbol": "IMNM",
"expires": "2026-12-18",
"open_interest": 2,
"option_type": "call",
"delta": 0.973362827278574,
"ask_volume": 1,
"last_price": "12.58",
"implied_volatility": "0.848805403443159",
"gamma": 0.00680126995945485,
"avg_price": "12.58",
"bid_volume": 0,
"nbbo_ask": "15.00",
"strike": "15",
"option_symbol": "IMNM261218C00015000",
"total_premium": "1258.00",
"iv": 0.620308109730921,
"volume": 1,
"nbbo_bid": "10.10"
},
{
"underlying_symbol": "IMNM",
"expires": "2026-12-18",
"open_interest": 17,
"option_type": "call",
"delta": 0.944044351872384,
"ask_volume": 0,
"last_price": "10.78",
"implied_volatility": "0.782624446800875",
"gamma": 0.01274212666171545,
"avg_price": "10.78",
"bid_volume": 1,
"nbbo_ask": "13.00",
"strike": "17",
"option_symbol": "IMNM261218C00017000",
"total_premium": "1078.00",
"iv": 0.605572980928604,
"volume": 1,
"nbbo_bid": "8.60"
},
{
"underlying_symbol": "IMNM",
"expires": "2026-09-18",
"open_interest": 62,
"option_type": "call",
"delta": 0.706782968470284,
"ask_volume": 0,
"last_price": "0.05",
"implied_volatility": null,
"gamma": 0.1572181710907294,
"avg_price": "0.05",
"bid_volume": 0,
"nbbo_ask": "4.90",
"strike": "26",
"option_symbol": "IMNM260918C00026000",
"total_premium": "5.00",
"iv": 0.396311971266469,
"volume": 1,
"nbbo_bid": "0.10"
},
{
"underlying_symbol": "IMNM",
"expires": "2026-09-18",
"open_interest": 686,
"option_type": "call",
"delta": 0.2219371067985933,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0896093382918441,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "30",
"option_symbol": "IMNM260918C00030000",
"total_premium": "0",
"iv": 0.600687122427741,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "IMNM",
"expires": "2026-12-18",
"open_interest": 407,
"option_type": "call",
"delta": 0.288914600224846,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0360804498646129,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "35",
"option_symbol": "IMNM261218C00035000",
"total_premium": "0",
"iv": 0.647570887857989,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "IMNM",
"expires": "2027-01-15",
"open_interest": 373,
"option_type": "call",
"delta": 0.481296936155486,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0360612881326785,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "30",
"option_symbol": "IMNM270115C00030000",
"total_premium": "0",
"iv": 0.672947704111904,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "IMNM",
"expires": "2027-01-15",
"open_interest": 237,
"option_type": "call",
"delta": 0.331759879062351,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0332770909050812,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "35",
"option_symbol": "IMNM270115C00035000",
"total_premium": "0",
"iv": 0.663884520896486,
"volume": 0,
"nbbo_bid": null
}
],
"gamma_profile": {
"ticker": "IMNM",
"spot": 27.11,
"date": "2026-09-03",
"flip_point": 19.38,
"net_gex": 16313.89,
"call_walls": [
{
"strike": 30.0,
"gex": 11566.7
},
{
"strike": 35.0,
"gex": 2374.1
},
{
"strike": 25.0,
"gex": 1832.67
}
],
"put_walls": [
{
"strike": 27.0,
"gex": -1347.23
},
{
"strike": 26.0,
"gex": -1080.6
},
{
"strike": 28.0,
"gex": -847.75
}
],
"by_strike": [
{
"strike": 15.0,
"call_gex": 4.45,
"put_gex": -172.96,
"net_gex": -168.51
},
{
"strike": 16.0,
"call_gex": 0.79,
"put_gex": -16.57,
"net_gex": -15.78
},
{
"strike": 17.0,
"call_gex": 24.61,
"put_gex": -16.81,
"net_gex": 7.8
},
{
"strike": 18.0,
"call_gex": 5.25,
"put_gex": -18.1,
"net_gex": -12.85
},
{
"strike": 19.0,
"call_gex": 1.98,
"put_gex": -1.63,
"net_gex": 0.35
},
{
"strike": 20.0,
"call_gex": 525.85,
"put_gex": -35.87,
"net_gex": 489.98
},
{
"strike": 21.0,
"call_gex": 2.58,
"put_gex": -31.74,
"net_gex": -29.16
},
{
"strike": 22.0,
"call_gex": 321.31,
"put_gex": -20.47,
"net_gex": 300.84
},
{
"strike": 23.0,
"call_gex": 103.2,
"put_gex": -33.32,
"net_gex": 69.88
},
{
"strike": 24.0,
"call_gex": 80.79,
"put_gex": -48.41,
"net_gex": 32.38
},
{
"strike": 25.0,
"call_gex": 1832.67,
"put_gex": -272.46,
"net_gex": 1560.21
},
{
"strike": 26.0,
"call_gex": 1127.6,
"put_gex": -1080.6,
"net_gex": 47.0
},
{
"strike": 27.0,
"call_gex": 268.02,
"put_gex": -1347.23,
"net_gex": -1079.21
},
{
"strike": 28.0,
"call_gex": 404.16,
"put_gex": -847.75,
"net_gex": -443.59
},
{
"strike": 29.0,
"call_gex": 643.11,
"put_gex": -9.5,
"net_gex": 633.6
},
{
"strike": 30.0,
"call_gex": 11566.7,
"put_gex": -49.33,
"net_gex": 11517.37
},
{
"strike": 31.0,
"call_gex": 493.42,
"put_gex": -8.0,
"net_gex": 485.43
},
{
"strike": 32.0,
"call_gex": 182.4,
"put_gex": -6.06,
"net_gex": 176.34
},
{
"strike": 33.0,
"call_gex": 81.1,
"put_gex": 0.0,
"net_gex": 81.1
},
{
"strike": 34.0,
"call_gex": 146.34,
"put_gex": 0.0,
"net_gex": 146.34
},
{
"strike": 35.0,
"call_gex": 2374.1,
"put_gex": -0.01,
"net_gex": 2374.09
},
{
"strike": 36.0,
"call_gex": 7.86,
"put_gex": 0.0,
"net_gex": 7.86
},
{
"strike": 37.0,
"call_gex": 125.91,
"put_gex": 0.0,
"net_gex": 125.91
},
{
"strike": 40.0,
"call_gex": 2.75,
"put_gex": 0.0,
"net_gex": 2.75
}
]
},
"oi_changes": {
"net_call_oi_change": -50,
"net_put_oi_change": 0,
"top": [
{
"strike": "30",
"oi_change": -50,
"type": "call"
},
{
"strike": "30",
"oi_change": 0,
"type": "call"
},
{
"strike": "35",
"oi_change": 0,
"type": "call"
},
{
"strike": "30",
"oi_change": 0,
"type": "call"
},
{
"strike": "35",
"oi_change": 0,
"type": "call"
}
]
},
"opds": {
"opds": -1.8,
"D": -4.5,
"P": -26.8,
"O": -35.8,
"C": 40.0,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": -19.6,
"T": 0.4,
"RS": -100.0,
"V": -0.0,
"F": -2.7,
"OI": -100.0,
"S": null,
"IV": -100.0,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": null,
"FlowAgreement": 100.0,
"StrikeBreadth": null
},
"drivers": [
"- open-interest change -100",
"- IV behaviour -100",
"- relative strength -100"
]
}
}
Data:
{
"vix": 14.92,
"sp500": 7686.14,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.41,
"hy_spread": 2.6,
"treasury": {
"date": "2026-09-01",
"month1": 3.85,
"month2": 3.89,
"month3": 3.92,
"month6": 4,
"year1": 4.18,
"year2": 4.39,
"year3": 4.46,
"year5": 4.55,
"year7": 4.66,
"year10": 4.79,
"year20": 5.27,
"year30": 5.27
},
"events": [
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.1%",
"actual": null,
"minutes_until": 1280
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "55K",
"previous": "-23K",
"actual": null,
"minutes_until": 1280
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 1280
}
]
}
Data:
{
"days": 106,
"patterns": [
{
"name": "VWAP Touch",
"count": 106,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 106,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 106,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 105,
"pct": 99
},
{
"name": "Woodie Pivot Touch",
"count": 99,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 91,
"pct": 86
},
{
"name": "Gap Fill",
"count": 83,
"pct": 78
},
{
"name": "Open Retracement",
"count": 76,
"pct": 72
},
{
"name": "Power Hour",
"count": 26,
"pct": 25
},
{
"name": "Darvas Box",
"count": 26,
"pct": 25
},
{
"name": "High Vol Open",
"count": 25,
"pct": 24
}
]
}